Status:
COMPLETED
New Therapy for Patients With Severe Tinnitus
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Tinnitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Tinnitus is a common problem for which there is no universally effective treatment. The best available estimates indicate that 10 - 15% of adults report having tinnitus symptoms, but only 20% of those...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Debilitating tinnitus, defined by score on the Tinnitus Hearing Inventory \> 38;
- Participation not ruled out by baseline medical exam (see below);
- Age 18 or older (no upper age limit);
- No acute systemic illness requiring frequent treatment such as chemotherapy, dialysis, and no such treatment in the past 3 months,
- Able to speak, read and write in English,
- Willingness to participate fully in either treatment arm when randomized,
- Not currently enrolled in another clinical trial or taking an experimental
- No previous experience with either Sound Based and Educational (SBE) therapies as applied in this study or an Integrated Medicine approach specifically for the treatment of tinnitus symptoms; and
- Adequate hearing to allow participation in the SBE treatment program.
Exclusion
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01480193
Start Date
September 1 2011
End Date
November 1 2013
Last Update
April 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27705